Jaguar Health (JAGX) Non-Current Assets (2014 - 2026)
Jaguar Health (JAGX) reported Non-Current Assets of $17.2 million for Q1 2026, down 18.06% year-over-year from $21.0 million in Q1 2025, and down 4.19% quarter-over-quarter from $18.0 million in Q4 2025.
Jaguar Health (JAGX) Non-Current Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Non-Current Assets data on file, last reported at $17.2 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $17.2 million, down 18.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.6 million (down 11.45% YoY), and the FY2025 annual result was $18.0 million, down 15.31% from the prior year.
- Non-Current Assets slipped to $17.2 million in Q1 2026 per JAGX's latest filing, from $18.0 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $26.5 million in Q2 2022 and troughed at $17.2 million in Q1 2026.
- A 5-year average of $22.3 million and a median of $21.8 million in 2024 frame the typical range for Non-Current Assets.
- On a YoY basis, Non-Current Assets climbed as much as 5.06% in 2022 and fell as far as 26.02% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $25.1 million in 2022, then dropped by 9.28% to $22.8 million in 2023, then slipped by 6.9% to $21.2 million in 2024, then retreated by 15.31% to $18.0 million in 2025, then dropped by 4.19% to $17.2 million in 2026.
- Business Quant data shows JAGX's Non-Current Assets at $17.2 million in Q1 2026, $18.0 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 62,953.78 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 39.71 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 17.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.22 Mn |
| Dec 31, 2025 | 17.98 Mn |
| Sep 30, 2025 | 20.07 Mn |
| Jun 30, 2025 | 20.37 Mn |
| Mar 31, 2025 | 21.02 Mn |
| Dec 31, 2024 | 21.23 Mn |
| Sep 30, 2024 | 21.82 Mn |
| Jun 30, 2024 | 21.35 Mn |
| Mar 31, 2024 | 21.68 Mn |
| Dec 31, 2023 | 22.80 Mn |
| Sep 30, 2023 | 23.32 Mn |
| Jun 30, 2023 | 23.95 Mn |
| Mar 31, 2023 | 24.57 Mn |
| Dec 31, 2022 | 25.13 Mn |
| Sep 30, 2022 | 26.08 Mn |
| Jun 30, 2022 | 26.52 Mn |
| Mar 31, 2022 | 24.43 Mn |
| Dec 31, 2021 | 24.83 Mn |
| Sep 30, 2021 | 35.25 Mn |
| Jun 30, 2021 | 25.25 Mn |